VFA CARDIAC RESYNCHRONIZATION THERAPY

    公开(公告)号:US20220111216A1

    公开(公告)日:2022-04-14

    申请号:US17558832

    申请日:2021-12-22

    Abstract: VfA cardiac therapy uses an implantable medical device or system. The implantable medical device includes a tissue-piercing electrode implanted in the basal and/or septal region of the left ventricular myocardium of the patient's heart from the triangle of Koch region of the right atrium through the right atrial endocardium and central fibrous body. The device may include a right atrial electrode, a right atrial motion detector, or both. The device may be implanted completely within the patient's heart or may use one or more leads to implant electrodes in the patient's heart. The device may be used to provide cardiac therapy, including single or multiple chamber pacing, atrioventricular synchronous pacing, asynchronous pacing, triggered pacing, cardiac resynchronization pacing, or tachycardia-related therapy. A separate medical device may be used to provide some functionality for cardiac therapy, such as sensing, pacing, or shock therapy.

    AV SYNCHRONOUS VFA CARDIAC THERAPY
    5.
    发明申请

    公开(公告)号:US20190290910A1

    公开(公告)日:2019-09-26

    申请号:US16361970

    申请日:2019-03-22

    Abstract: VfA cardiac therapy uses an implantable medical device or system. The implantable medical device includes a tissue-piercing electrode implanted in the basal and/or septal region of the left ventricular myocardium of the patient's heart from the triangle of Koch region of the right atrium through the right atrial endocardium and central fibrous body. The device may include a right atrial electrode, a right atrial motion detector, or both. The device may be implanted completely within the patient's heart or may use one or more leads to implant electrodes in the patient's heart. The device may be used to provide cardiac therapy, including single or multiple chamber pacing, atrioventricular synchronous pacing, asynchronous pacing, triggered pacing, cardiac resynchronization pacing, or tachycardia-related therapy. A separate medical device may be used to provide some functionality for cardiac therapy, such as sensing, pacing, or shock therapy.

    CARDIAC RESYNCHRONIZATION THERAPY DIAGNOSTICS

    公开(公告)号:US20190209846A1

    公开(公告)日:2019-07-11

    申请号:US15928714

    申请日:2018-03-22

    CPC classification number: A61N1/3702 A61B5/0456 A61N1/371 A61N1/3937

    Abstract: In some examples, a system can be used for delivering cardiac resynchronization therapy (CRT). The system may include a pacing device configured to be implanted within a patient. The pacing device can include a plurality of electrodes, signal generation circuitry configured to deliver ventricular pacing via the plurality of electrodes, and a sensor configured to produce a signal that indicates mechanical activity of the heart. Processing circuitry can be configured to identify one or more features of a cardiac contraction within the signal, and determine whether the contraction was a fusion beat based on the one or more features.

    Bi-atrial synchronized left ventricular cardiac pacing
    7.
    发明授权
    Bi-atrial synchronized left ventricular cardiac pacing 有权
    双心室同步左心室心脏起搏

    公开(公告)号:US09233251B2

    公开(公告)日:2016-01-12

    申请号:US14157161

    申请日:2014-01-16

    CPC classification number: A61N1/3682 A61N1/368 A61N1/3684

    Abstract: A medical device performs a method for controlling a cardiac pacing therapy. The device determines an inter-atrial conduction time (IACT) and compares the IACT to a threshold. A controller included in the device sets a pacing interval for controlling delivery of pacing pulses to a ventricle to a first ventricular pacing interval that expires after the IACT in response to the IACT being less than the threshold and sets the pacing interval to a second ventricular pacing interval that expires before the IACT in response to the IACT being greater than the threshold.

    Abstract translation: 医疗装置执行用于控制心脏起搏治疗的方法。 该装置确定心房间传导时间(IACT)并将IACT与阈值进行比较。 包括在装置中的控制器设置起搏间隔,用于控制向心室递送起搏脉冲到响应于IACT小于阈值的IACT之后到期的第一心室起搏间隔,并将起搏间隔设定为第二心室起搏 响应于IACT大于阈值在IACT之前到期的间隔。

Patent Agency Ranking